IVA

Inventiva S.A. - American Depos

2.68

Top Statistics
Market Cap 219 M Forward PE -1.67 Revenue Growth -58.70 %
Current Ratio 0.59 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -2.07 Enterprise / Revenue 10.56 Price To Sales Trailing12 Months 11.40
Profitability
Profit Margins 0.00 % Operating Margins -1911.08 %
Balance Sheet
Total Cash 10 M Total Cash Per Share 0.1990 Total Debt 73 M
Total Debt To Equity Current Ratio 0.59 Book Value Per Share -1.51
All Measures
Short Ratio 480.00 % Message Board Id finmb_273516426 Shares Short Prior Month 853441
City Daix Uuid 482cc7a0-aa3a-38d9-b65d-b974eb27bb5d Previous Close 2.62
First Trade Date Epoch Utc 1 B Book Value -1.51 Beta 0.8050
Total Debt 73 M Volume 12915 Fifty Two Week Low 1.53
Total Cash Per Share 0.1990 Total Revenue 19 M Shares Short Previous Month Date 1 B
Target Median Price 12.50 Max Age 86400 Recommendation Mean 1.50
Sand P52 Week Change 0.3133 Operating Margins -1911.08 % Target Mean Price 12.43
Net Income To Common -104186000 Short Percent Of Float 0.0140 Implied Shares Outstanding 82 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 16030
Average Volume10days 16030 Total Cash 10 M Next Fiscal Year End 1 B
Revenue Per Share 0.3830 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 2.62 Target Low Price 3.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.40 Open 2.61
Free Cashflow -49413124 Dividend Yield 0.00 % Return On Assets -1.13
Time Zone Short Name EST Trailing Eps -2.16 Day Low 2.61
Address1 50 rue de Dijon Shares Outstanding 52 M Price Hint 4
Target High Price 20.00 Website https://www.inventivapharma.com 52 Week Change -0.3619
Average Volume 210968 Recommendation Key strong_buy Forward Eps 0.0000
Compensation As Of Epoch Date 1 B Quick Ratio 44.00 % Is_sp_500 False
Regular Market Day High 2.78 Profit Margins 0.00 % Fifty Two Week High 4.75
Day High 2.78 Shares Short 390299 Regular Market Open 2.61
Industry Key biotechnology Earnings Growth 0.00 % Enterprise To Revenue 10.56
Revenue Growth -58.70 % Shares Percent Shares Out 0.0075 Operating Cashflow -84723000
Currency USD Time Zone Full Name America/New_York Market Cap 219 M
Is_nasdaq_100 False Zip 21121 Quote Type EQUITY
Industry Biotechnology Long Name Inventiva S.A. Regular Market Day Low 2.61
Held Percent Institutions 0.0558 Current Price 2.68 Enterprise To Ebitda -2.07
Financial Currency EUR Current Ratio 0.59 Gross Margins 94.38 %
Industry Disp Biotechnology Number Of Analyst Opinions 6 Country France
Float Shares 10 M Two Hundred Day Average 2.91 Enterprise Value 203 M
Price To Sales Trailing12 Months 11.40 Forward PE -1.67 Regular Market Volume 12915
Ebitda -98356000 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha
Inventiva S.

A.

, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases.

Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH.

The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI.

In addition, it has a pipeline of earlier stage programs in oncology and other diseases.

The company was founded in 2011 and is headquartered in Daix, France.